| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.8B | $0.5B | $0.6B | $0.9B | $1.3B | $0.7B | $0.9B | $0.4B |
| EPS (Basic) | $6.59 | $4.26 | $5.33 | $7.07 | $9.90 | $2.67 | $1.92 | $1.24 |
| EPS (Diluted) | $6.56 | $4.24 | $5.32 | $7.06 | $9.87 | $2.67 | $1.91 | $1.24 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $27.4B | $25.9B | $24.3B | $22.5B | $22.1B | $22.5B | $22.8B | $20.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.9B | $0.5B | $1.0B | $0.5B | $0.5B | $2.3B | $1.2B | $0.7B |
| Total Liabilities | $24.0B | $22.7B | $21.1B | $19.5B | $19.0B | $19.0B | $18.5B | $16.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.4B | $3.2B | $3.2B | $3.0B | $3.1B | $3.4B | $4.3B | $3.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.1B | $2.7B | $2.5B | $2.4B | $2.2B | $2.2B | $2.4B | $2.0B |
| Investing Cash Flow | $-3.2B | $-3.3B | $-2.9B | $-2.1B | $-2.1B | $-0.8B | $-3.4B | $-2.4B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.5B | $0.2B | $0.9B | $-0.3B | $-1.8B | $-0.4B | $1.5B | $0.0B |